Profil
M.
Alexander Shaw formerly worked at Prolifagen, Inc., as Chief Executive Officer and Nuventra, Inc., as Chief Operating Officer from 2009 to 2021.
Dr. Shaw received his undergraduate degree from Duke University and doctorate degree from Washington State University.
Anciens postes connus de M. Alexander Shaw
| Sociétés | Poste | Fin |
|---|---|---|
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Directeur des opérations | 01/10/2021 |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Directeur Général | - |
Formation de M. Alexander Shaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Commercial Services |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
















